Zelda to ZeliraThe Zelira moniker is an amalgam of Zelda and Ilera, which as far as concocted names go is a fairly logical and elegant one.The California based Zelda back-door listed on the ASX on November 22, 2016, having raised $4 million at 2.5 cents apiece. The name derived from the company’s association with pot shop Aunt Zelda’s, also founded by Zelda co-founder Mara Gordon.Zelda’s other founders were local biotech likely lads Harry Karelis (Titan Capital Partners), Dr Stewart Washer (lots of biotech boards) and Jason Peterson from CPS Capital.Aimed at becoming one of the few marijuana companies with clinical validation, Zelda entered a baffling array of liaisons and collaborations. Partners include or included the listed pot stock Auscann in a joint venture in Chile; and Suda Pharmaceuticals to develop an oral mist delivery product.In keeping with the company’s Perth domicile, the local medical research house Telethon Kids Institute and Curtin University are also research partners.Zelira also has a tie-up with the recently listed Emerald Clinics (with chairman Dr Stewart Washer), in view of accessing data for patients treated for pain and insomnia.In May 2018, the company recruited molecular biologist Dr Richard Hopkins as CEO. Dr Hopkins formerly led the ASX listed doggie drug play Pharmaust; and previous to that led and co-founded Phylogica, with Dr Stewart Washer and Harry Karelis.
ZLD Price at posting:
$1.03 Sentiment: Buy Disclosure: Held
